CISD3

gene
On this page

Also known as Miner2MiNT

Summary

CISD3 (CDGSH iron sulfur domain 3, HGNC:27578) is a protein-coding gene on chromosome 17q12, encoding CDGSH iron-sulfur domain-containing protein 3, mitochondrial (P0C7P0). Can transfer its iron-sulfur clusters to the apoferrodoxins FDX1 and FDX2.

CISD3 is a member of the CDGSH domain-containing family, which may play a role in regulating electron transport and oxidative phosphorylation (Wiley et al., 2007 [PubMed 17376863]).

Source: NCBI Gene 284106 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 130 total
  • MANE Select transcript: NM_001136498

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:27578
Approved symbolCISD3
NameCDGSH iron sulfur domain 3
Location17q12
Locus typegene with protein product
StatusApproved
AliasesMiner2, MiNT
Ensembl geneENSG00000277972
Ensembl biotypeprotein_coding
OMIM611933
Entrez284106

Gene structure

Transcript identifiers

Ensembl transcripts: 7 — 5 protein_coding, 2 retained_intron

ENST00000613478, ENST00000616128, ENST00000619858, ENST00000894448, ENST00000894449, ENST00000894450, ENST00000939173

RefSeq mRNA: 1 — MANE Select: NM_001136498 NM_001136498

CCDS: CCDS45662

Canonical transcript exons

ENST00000613478 — 4 exons

ExonStartEnd
ENSE000037325353873132038731439
ENSE000037368933873327638735605
ENSE000037400303873076038730795
ENSE000037495803873034138730406

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 97.74.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 12.2557 / max 82.9579, expressed in 1797 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
16051611.01841778
1605151.2373882

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
mucosa of transverse colonUBERON:000499197.74gold quality
apex of heartUBERON:000209897.11gold quality
right lobe of liverUBERON:000111497.06gold quality
liverUBERON:000210795.80gold quality
body of pancreasUBERON:000115095.49gold quality
duodenumUBERON:000211495.30gold quality
heart left ventricleUBERON:000208495.21gold quality
transverse colonUBERON:000115794.28gold quality
right adrenal glandUBERON:000123393.90gold quality
adult mammalian kidneyUBERON:000008293.80gold quality
left adrenal gland cortexUBERON:003582593.80gold quality
left adrenal glandUBERON:000123493.65gold quality
right atrium auricular regionUBERON:000663193.52gold quality
heartUBERON:000094893.49gold quality
body of stomachUBERON:000116193.43gold quality
right adrenal gland cortexUBERON:003582793.30gold quality
prefrontal cortexUBERON:000045192.94gold quality
small intestine Peyer’s patchUBERON:000345492.75gold quality
small intestineUBERON:000210892.62gold quality
hindlimb stylopod muscleUBERON:000425292.62gold quality
colonUBERON:000115592.58gold quality
fundus of stomachUBERON:000116092.42gold quality
granulocyteCL:000009492.31gold quality
left coronary arteryUBERON:000162692.20gold quality
intestineUBERON:000016092.00gold quality
muscle layer of sigmoid colonUBERON:003580591.91gold quality
pancreasUBERON:000126491.80gold quality
gastrocnemiusUBERON:000138891.74gold quality
adrenal glandUBERON:000236991.64gold quality
muscle of legUBERON:000138391.54gold quality

Single-cell (SCXA)

Detected in 5 experiment(s), a significant marker in 5.

ExperimentMarker?Max mean expression
E-MTAB-8410yes45.73
E-ANND-3yes17.65
E-CURD-112yes13.21
E-MTAB-9543yes10.01
E-HCAD-13yes7.13

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

95 targeting CISD3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-5193100.0067.261744
HSA-MIR-188-3P100.0068.761240
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-574-5P100.0066.01989
HSA-MIR-4776-3P100.0068.731340
HSA-MIR-10401-5P99.9965.79948
HSA-MIR-477599.9875.006394
HSA-MIR-19A-3P99.9875.332762
HSA-MIR-19B-3P99.9875.442754
HSA-MIR-314899.9775.066478
HSA-MIR-6835-3P99.9370.492904
HSA-MIR-6721-5P99.9368.922981
HSA-MIR-548E-5P99.8972.734486
HSA-MIR-153-5P99.8973.866317
HSA-MIR-612499.8769.783551
HSA-MIR-444799.8567.812900
HSA-MIR-4639-5P99.8167.371028
HSA-MIR-7110-5P99.8067.841712
HSA-MIR-6842-5P99.8067.541587
HSA-MIR-1296-3P99.7264.04636
HSA-MIR-472999.6972.184233
HSA-MIR-6512-3P99.6566.071468
HSA-MIR-6720-5P99.6566.221459
HSA-MIR-1260A99.6166.671098
HSA-MIR-1260B99.6166.671098
HSA-MIR-1249-5P99.6166.552049
HSA-MIR-6797-5P99.6166.552084

Literature-anchored findings (GeneRIF, showing 3)

  • Data indicate that mitochondrial inner NEET protein (MiNT)functions within the mitochondria to regulate levels of toxic iron and reactive oxygen species (ROS). (PMID:29259115)
  • CISD3 inhibition drives cystine-deprivation induced ferroptosis. (PMID:34497268)
  • Biochemical and cellular characterization of the CISD3 protein: Molecular bases of cluster release and destabilizing effects of nitric oxide. (PMID:38354784)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
mus_musculusCisd3ENSMUSG00000078695
rattus_norvegicusCisd3ENSRNOG00000036894
drosophila_melanogasterCG3420FBGN0033100
caenorhabditis_elegansWBGENE00022053

Paralogs (2): CISD1 (ENSG00000122873), CISD2 (ENSG00000145354)

Protein

Protein identifiers

CDGSH iron-sulfur domain-containing protein 3, mitochondrialP0C7P0 (reviewed: P0C7P0)

Alternative names: MitoNEET-related protein 2, Mitochondrial inner NEET protein

All UniProt accessions (1): P0C7P0

UniProt curated annotations — full annotation on UniProt →

Function. Can transfer its iron-sulfur clusters to the apoferrodoxins FDX1 and FDX2. Contributes to mitochondrial iron homeostasis and in maintaining normal levels of free iron and reactive oxygen species, and thereby contributes to normal mitochondrial function.

Subunit / interactions. Monomer.

Subcellular location. Mitochondrion.

Cofactor. Binds 2 [2Fe-2S] clusters per subunit.

Similarity. Belongs to the CISD protein family.

RefSeq proteins (1): NP_001129970* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR018967FeS-contain_CDGSH-typDomain
IPR042216MitoNEET_CISDHomologous_superfamily
IPR052950CISDFamily

Pfam: PF09360

UniProt features (24 total): binding site 8, strand 6, modified residue 3, helix 3, mutagenesis site 2, transit peptide 1, chain 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
6AVJX-RAY DIFFRACTION1.9

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P0C7P0-F187.670.72

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (8): 60; 62; 71; 75; 98; 100; 109; 113

Post-translational modifications (3): 55, 55, 86

Mutagenesis-validated functional residues (2):

PositionPhenotype
75increases iron-sulfur cluster stability; when associated with c-113.
113increases iron-sulfur cluster stability; when associated with c-75.

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 95 (showing top): GOBP_PROTEIN_MATURATION, GOMF_METAL_CLUSTER_BINDING, GOMF_2_IRON_2_SULFUR_CLUSTER_BINDING, RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN, VANLOO_SP3_TARGETS_DN, ATF6_TARGET_GENES, BARX1_TARGET_GENES, CREB3L4_TARGET_GENES, DLX6_TARGET_GENES, FOXD2_TARGET_GENES, ID1_TARGET_GENES, ID2_TARGET_GENES, NAB2_TARGET_GENES, SNRNP70_TARGET_GENES, UBN1_TARGET_GENES

GO Biological Process (1): protein maturation (GO:0051604)

GO Molecular Function (3): metal ion binding (GO:0046872), 2 iron, 2 sulfur cluster binding (GO:0051537), iron-sulfur cluster binding (GO:0051536)

GO Cellular Component (3): mitochondrion (GO:0005739), cytoplasm (GO:0005737), intracellular membrane-bounded organelle (GO:0043231)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
intracellular anatomical structure2
gene expression1
protein metabolic process1
cation binding1
iron-sulfur cluster binding1
metal cluster binding1
cytoplasm1
intracellular membrane-bounded organelle1
cellular anatomical structure1
membrane-bounded organelle1
intracellular organelle1

Protein interactions and networks

STRING

808 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CISD3CISD1Q9NZ45991
CISD3CISD2Q8N5K1962
CISD3FDX1P10109540
CISD3RPL28P46779454
CISD3CIMAP1CQ8IXM7453
CISD3MNTQ99583447
CISD3HSPB3Q12988437
CISD3CFTRP13569424
CISD3RPL27AP46776424
CISD3CPEB2Q7Z5Q1420
CISD3CIAPIN1Q6FI81418
CISD3ACO1P21399404
CISD3WFS1O76024386
CISD3ATXN7L3BQ96GX2384
CISD3DNAJC30Q96LL9380

IntAct

24 interactions, top by confidence:

ABTypeScore
CHCHD4SSNA1psi-mi:“MI:0914”(association)0.640
LRFN4RIMOC1psi-mi:“MI:0914”(association)0.530
CACNG5ZNF316psi-mi:“MI:0914”(association)0.530
HAVCR2TCAF2psi-mi:“MI:0914”(association)0.530
ADAM33LRP5psi-mi:“MI:0914”(association)0.530
PLOD2psi-mi:“MI:0914”(association)0.530
NCAPD3SMC2psi-mi:“MI:0914”(association)0.350
SMOC1NME2psi-mi:“MI:0914”(association)0.350
CISD3POLRMTpsi-mi:“MI:0914”(association)0.350
CISD3COQ9psi-mi:“MI:0914”(association)0.350
CISD3TIMM44psi-mi:“MI:0914”(association)0.350
IGF1RHAX1psi-mi:“MI:0914”(association)0.350
S100BPLEKHG3psi-mi:“MI:0914”(association)0.350
ADAM33ADAM10psi-mi:“MI:0914”(association)0.350
ABCA6STX6psi-mi:“MI:0914”(association)0.350
SLC30A1PSMD11psi-mi:“MI:0914”(association)0.350
SLC31A1DENND11psi-mi:“MI:0914”(association)0.350
STAT3IDH3Bpsi-mi:“MI:0914”(association)0.350

BioGRID (100): CISD3 (Affinity Capture-MS), CISD3 (Affinity Capture-MS), MIPEP (Affinity Capture-MS), ERAL1 (Affinity Capture-MS), AFG3L2 (Affinity Capture-MS), CLPX (Affinity Capture-MS), GRSF1 (Affinity Capture-MS), SCO2 (Affinity Capture-MS), CLPB (Affinity Capture-MS), PMPCA (Affinity Capture-MS), PMPCB (Affinity Capture-MS), TRMT10C (Affinity Capture-MS), POLRMT (Affinity Capture-MS), CHCHD2 (Affinity Capture-MS), STOML2 (Affinity Capture-MS)

ESM2 similar proteins: A0A1L1SUL6, A4QJJ7, A4QK16, A6H5F6, A6MM34, A6NH52, A6NMK7, A7M939, A8SEA1, A8W3M5, B0Z4S1, B0Z505, B0Z589, B0Z5H3, B1AR13, B1NWE8, B2LMJ1, O19048, O19137, O95639, P0C7P0, P0DI19, P46292, P60335, P83870, P83871, P98138, Q09G48, Q0G9M1, Q0WMV8, Q15365, Q1KXW1, Q332Y0, Q5E9A3, Q5FVR7, Q5R654, Q63789, Q66KE3, Q68S08, Q6DJP7

Diamond homologs: B1AR13, P0C7P0

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

130 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance81
Likely benign32
Benign6

Top pathogenic / likely-pathogenic (0)

SpliceAI

499 predictions. Top by Δscore:

VariantEffectΔscore
17:38735596:CCGTT:Cacceptor_gain1.0000
17:38735597:CGTT:Cacceptor_gain1.0000
17:38735597:CGTTC:Cacceptor_gain1.0000
17:38735598:GTT:Gacceptor_gain1.0000
17:38735599:TT:Tacceptor_gain1.0000
17:38735601:C:CCacceptor_gain1.0000
17:38735601:C:CGacceptor_loss1.0000
17:38735602:T:Gacceptor_loss1.0000
17:38730716:A:AGacceptor_gain0.9900
17:38730717:A:Gacceptor_gain0.9900
17:38731843:G:GGdonor_gain0.9900
17:38731311:T:TAacceptor_gain0.9800
17:38731435:AGCAG:Adonor_loss0.9800
17:38731436:GCAGG:Gdonor_loss0.9800
17:38731437:CAGGT:Cdonor_loss0.9800
17:38731438:AG:Adonor_loss0.9800
17:38731439:GGTGA:Gdonor_loss0.9800
17:38731440:G:Adonor_loss0.9800
17:38731441:TGAGA:Tdonor_loss0.9800
17:38731906:G:GAdonor_gain0.9800
17:38730403:CCGGG:Cdonor_loss0.9700
17:38730404:CGGGT:Cdonor_loss0.9700
17:38730405:GGGTG:Gdonor_loss0.9700
17:38730406:GGT:Gdonor_loss0.9700
17:38730407:G:Cdonor_loss0.9700
17:38730408:T:Adonor_loss0.9700
17:38730409:GAGCA:Gdonor_loss0.9700
17:38731411:G:GAdonor_gain0.9700
17:38731442:GAGAC:Gdonor_loss0.9700
17:38731883:A:Gdonor_gain0.9700

AlphaMissense

812 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:38733374:G:CK101N0.990
17:38733374:G:TK101N0.990
17:38731412:G:CW59C0.989
17:38731412:G:TW59C0.989
17:38733331:T:CF87S0.988
17:38731423:G:TG63V0.985
17:38731429:G:TS65I0.985
17:38733283:G:AC71Y0.985
17:38731423:G:AG63D0.984
17:38733330:T:CF87L0.983
17:38733332:C:AF87L0.983
17:38733332:C:GF87L0.983
17:38731410:T:AW59R0.982
17:38731410:T:CW59R0.982
17:38733363:T:CC98R0.982
17:38733363:T:AC98S0.981
17:38733364:G:CC98S0.981
17:38733396:T:AC109S0.981
17:38733397:G:CC109S0.981
17:38733282:T:AC71S0.980
17:38733283:G:CC71S0.980
17:38731419:T:CC62R0.979
17:38733282:T:CC71R0.979
17:38731428:A:CS65R0.978
17:38731430:C:AS65R0.978
17:38731430:C:GS65R0.978
17:38733365:T:GC98W0.978
17:38733397:G:AC109Y0.978
17:38731419:T:AC62S0.977
17:38731420:G:CC62S0.977

dbSNP variants (sampled 300 via entrez): RS1000215071 (17:38730592 C>G,T), RS1000227757 (17:38731012 G>A), RS1000257530 (17:38731266 C>T), RS1000711107 (17:38730913 G>A), RS1001158702 (17:38732002 C>T), RS1001212193 (17:38732140 T>G), RS1001230984 (17:38732350 T>C), RS1002226020 (17:38733806 T>A), RS1002286801 (17:38733658 G>A), RS1002319370 (17:38734071 C>A,T), RS1003058969 (17:38729418 G>A), RS1003090286 (17:38729652 C>T), RS1003225700 (17:38734750 G>A), RS1003229373 (17:38735369 G>T), RS1003687402 (17:38734916 G>C)

Disease associations

OMIM: gene MIM:611933 | disease phenotypes: MIM:604928, MIM:618371

GenCC curated gene-disease

Mondo (2): Wolfram syndrome 2 (MONDO:0011502), turnpenny-fry syndrome (MONDO:0032707)

Orphanet (2): Wolfram syndrome (Orphanet:3463), Turnpenny-Fry syndrome (Orphanet:688642)

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST004185_4Lung function (FEV1/FVC)7.000000e-11

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004713FEV/FVC ratio

MeSH disease descriptors (1)

DescriptorNameTree numbers
C565733Wolfram Syndrome 2 (supp.)

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

19 total (human), top 19 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arseniteincreases expression, decreases expression, affects cotreatment, increases abundance3
Benzo(a)pyreneaffects methylation, increases expression2
aristolochic acid Idecreases expression1
GSK-J4decreases expression1
manganese chlorideaffects cotreatment, increases abundance, increases expression1
di-n-butylphosphoric acidaffects expression1
perfluorooctane sulfonic acidincreases expression1
NSC 689534affects binding, decreases expression1
Acetaminophendecreases expression1
Arsenicincreases abundance, increases expression, affects cotreatment1
Copperaffects binding, decreases expression1
Ethyl Methanesulfonatedecreases expression1
Manganeseaffects cotreatment, increases abundance, increases expression1
Methyl Methanesulfonatedecreases expression1
Naledaffects expression1
Smokedecreases expression1
Thiramdecreases expression1
Urethanedecreases expression1
Valproic Acidaffects expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): turnpenny-fry syndrome, Wolfram syndrome 2